Who is sponsoring NCT04426734?

NCT04426734 is sponsored by New England Retina Associates.

What drugs are being tested in NCT04426734?

Interventions in NCT04426734: Dextenza Dexamethasone Implant, Topical Prednisolone Acetate 1%.

What condition does NCT04426734 study?

NCT04426734 studies Non-infectious Anterior Uveitis.

Is NCT04426734 still recruiting?

NCT04426734 is currently status unknown. Last updated 11 June 2020.

Last reviewed 2020-06-11 · How we verify

NCT04426734: DiverT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of DEXTENZA in the Management of Pain and Inflammation in Patients With Anterior Uveitis Compared to Standard of Care Topical Corticosteroids

Status unknown Phase 4 Last updated 11 June 2020

What this trial tests

Phase 4 trial testing Dextenza Dexamethasone Implant in Non-infectious Anterior Uveitis in 30 participants. Status unknown.

Timeline

1 July 2020

Primary endpoint
31 December 2020

31 March 2021

Quick facts

Lead sponsor	New England Retina Associates
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	1 July 2020
Primary completion	31 December 2020
Estimated completion	31 March 2021

Drugs / interventions tested

Dextenza Dexamethasone Implant
Topical Prednisolone Acetate 1% — full drug profile →

Conditions studied

Non-infectious Anterior Uveitis — all drugs for Non-infectious Anterior Uveitis →

Sponsor

New England Retina Associates — full company profile →

Who can join

18 and older, any sex, with Non-infectious Anterior Uveitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This a prospective study review of the clinical efficacy of DEXTENZA for the treatment of anterior uveitis compared to the standard of care topical corticosteroid treatment

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04426734 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by New England Retina Associates
Last refreshed: 11 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04426734.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing